New genomic and proteomic biomarker discovery in cancer: revolutionizing diagnosis and prognostication

Puntos clave

• New genomic and proteomic biomarkers significantly enhance cancer diagnosis and prognosis, enabling better outcomes.
• The analysis revealed multiple biomarkers associated with improved accuracy in distinguishing cancer types, supporting the findings.
• Observational analysis focused on novel biomarkers and their impact on diagnostic accuracy and prognostication.
• These findings suggest a critical shift in cancer care, aiming to personalize treatment and improve patient outcomes.